Aphasia Clinical Trial
— PROCoMOfficial title:
Double-blind Randomized Trial Investigating the Use of Computational Modeling to Predict Rehabilitation Outcomes in Bilingual Aphasia
The purpose of this investigation is to implement a computational model that can predict and optimize training and cross-language generalization patterns for bilingual persons with aphasia (BPA). The proposed work will determine the best possible treatment program for each individual patient even before they are rehabilitated. In addition, the computational model allows specification of variables such as age of acquisition, language exposure/proficiency, impairment and their systematic influence on a range of language rehabilitation outcomes.
| Status | Recruiting |
| Enrollment | 48 |
| Est. completion date | July 31, 2023 |
| Est. primary completion date | July 31, 2021 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 85 Years |
| Eligibility | Inclusion Criteria: - Any number of years of education - Bilingual: speaking both Spanish and English (or Chinese and English) with any degree of language proficiency prior to stroke - Aphasia secondary to a left-hemisphere stroke (diagnosed by a neurologist on the basis of clinical CT/MRI imaging or medical reports) - Aphasia resulting from stroke or dementia - Naming deficits must be present with concurrent lexical/semantic impairment - Visual and auditory acuity sufficient for all assessment and treatment procedures - Ability to understand study and follow study procedures for the entire length of the study Exclusion Criteria: - Premorbid history of speech/language disorder - Proficient in more than just Spanish and English (or Chinese and English) - Overt, behaviorally noticeable, attentional limitations that interfere with completing the experimental tasks - Active medical disease that may compromise participation (e.g., cancer undergoing acute treatment, unstable diabetes, renal or hepatic insufficiency, fluctuating systemic immunological disease such as systemic lupus erythematosis, etc.) - Currently taking medications that are known to exert significant effects on cognitive processes, such as neuroleptics, steroids, anticholinesterase inhibitors, etc. - Current drug or alcohol use or dependence that would interfere with adherence to study requirements, in the opinion of the principal investigator - Inability or unwillingness of individual to give written informed consent - Diagnosed with mental illness other than active depression - Neurological condition other than that which resulted in aphasia |
| Country | Name | City | State |
|---|---|---|---|
| United States | Austin Speech Labs | Austin | Texas |
| United States | Boston University Sargent College | Boston | Massachusetts |
| United States | San Francisco State University | San Francisco | California |
| Lead Sponsor | Collaborator |
|---|---|
| Boston University Charles River Campus | National Institute on Deafness and Other Communication Disorders (NIDCD) |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Word Retrieval Accuracy in both languages | Accuracy of naming of pictured treated and untreated items in both languages will be assessed in probes conducted separate from treatment. Probes were conducted repeatedly throughout the study, from baseline (prior to treatment) to the end of treatment. All naming responses were scored using as correct or incorrect. A percentage accuracy was calculated for each set of items for every probe session. Baseline probe scores were compared to end of treatment probe scores to obtain individual effect sizes for each sets of items for each participant (i.e., several effect sizes were calculated for each participant). | Through study completion, an average of 10 weeks | |
| Secondary | Psycholinguistic assessments of language processing in aphasia (PALPA) in both languages | Reading single words and understanding spoken words | Week 1 and up to 10 weeks | |
| Secondary | Boston Naming Test (BNT) in both languages | Naming pictured items | Week 1 and up to 10 weeks | |
| Secondary | Bilingual Aphasia Test (BAT) B and C in both languages | Assesses each of the languages of a bilingual or multilingual individual with aphasia | Week 1 and up to 10 weeks | |
| Secondary | Western Aphasia Battery (WAB) in both languages | Assesses the levels of impairment of aphasia | Week 1 and up to 10 weeks | |
| Secondary | Cognitive Linguistic Quick Test (CLQT) in both languages | Assesses the contribution of cognitive deficits to language dysfunction | Week 1 and up to 10 weeks | |
| Secondary | Verbal fluency task (COWAT) in both languages | Assesses general fluency | Week 1 and up to 10 weeks | |
| Secondary | Category fluency task in both languages | Assesses category fluency | Week 1 and up to 10 weeks | |
| Secondary | Communication Effectiveness Index (CETI) for both languages | Determines communication effectiveness by proxy | Week 1 and up to 10 weeks | |
| Secondary | Pyramids and Palm Trees Test (PAPT) 3 pictures version | Assesses semantic processing ability | Week 1 and up to 10 weeks | |
| Secondary | Aphasia Bank | Assesses discourse | Week 1 and up to 10 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03622411 -
Tablet-based Aphasia Therapy in the Chronic Phase
|
N/A | |
| Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
| Recruiting |
NCT03929432 -
Treatment Outcomes With tDCS in Post-Stroke Aphasia
|
N/A | |
| Completed |
NCT03662295 -
Stroke-like Migraine Attacks After Radiation Treatment (SMART) Syndrome Language Intervention
|
||
| Completed |
NCT03679637 -
Tablet-based Aphasia Therapy in the Acute Phase After Stroke
|
N/A | |
| Completed |
NCT03550092 -
Analysis of Brain Activity to Uncover Brain-behavior Relationships Related to Therapy Outcomes in Aphasia
|
N/A | |
| Completed |
NCT03228264 -
A Trial Investigating Telerehabilitation as an add-on to Face-to-face Speech and Language Therapy in Post-stroke Aphasia.
|
N/A | |
| Suspended |
NCT04290988 -
Circuitry Assessment and Reinforcement Training Effects on Recovery
|
N/A | |
| Recruiting |
NCT05969548 -
pBFS-guided cTBS at Different Doses for Aphasia After Stroke
|
N/A | |
| Recruiting |
NCT04138940 -
Modulating Intensity and Dosage of Aphasia Scripts
|
N/A | |
| Terminated |
NCT02249819 -
Evaluating Anodal tDCS Preceding Aphasia Therapy
|
Phase 1/Phase 2 | |
| Completed |
NCT01654029 -
Patient Centred Communication Intervention
|
N/A | |
| Completed |
NCT00843427 -
fMRI of Language Recovery Following Stroke in Adults
|
N/A | |
| Active, not recruiting |
NCT00227461 -
Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.
|
Phase 1 | |
| Completed |
NCT03773419 -
Improving Electronic Written Communication in Aphasia
|
N/A | |
| Not yet recruiting |
NCT04142866 -
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
|
N/A | |
| Suspended |
NCT04048668 -
tDCS to Treat Subacute Aphasia
|
N/A | |
| Recruiting |
NCT04081207 -
Using Augmentative & Alternative Communication to Promote Language Recovery for People With Post-Stroke Aphasia
|
N/A | |
| Completed |
NCT02226796 -
Transcranial Direct Stimulation (tDCS) and Behavioral Intervention in Aphasia
|
N/A | |
| Completed |
NCT01163461 -
Phonomotor Treatment of Word Retrieval Deficits in Individuals With Aphasia
|
N/A |